Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ·Healthcare·Biotechnology
$50.91
+0.71%
Mkt Cap $944.27M
Analyst Ratings
Buy
7
Hold
1
Sell
0
Price Target (6 analysts)
$67.00
Range $49.00 – $85.00
Implied Upside
+31.6%
Consensus $67.00 vs current $50.91
NASDAQ·Healthcare·Biotechnology
$50.91
+0.71%
Mkt Cap $944.27M
Buy
7
Hold
1
Sell
0
Price Target (6 analysts)
$67.00
Range $49.00 – $85.00
+31.6%
Consensus $67.00 vs current $50.91